| Blueprint ID | Learning Objectives |
| 8159 | Distinguish between the harm resulting from an adverse event and the natural progression of patient’s underlying medical condition |
| 8160 | Identify the immediate safety and care needs for the physical and emotional well-being of patients and their families, and provide interventions as appropriate |
| 8161 | Reduce or manage the risk of further harm to patients affected by adverse events and close calls |
| 8162 | Describe what information should be disclosed at the initial disclosure stage, the time frame for disclosure, and the relevant documentation, reporting, and analyses |
| 8163 | Describe the ethical, professional and legal obligation to disclose and report adverse events |
| 8164 | Differentiate between disclosure and reporting and the inherent processes associated with each concept |
| 8165 | Identify the existing policies and procedures associated with disclosure and the extent to which these foster a culture of patient safety |
| 8166 | Demonstrate honest communication and empathic dialogue with respect to disclosure |
| 8167 | Explain the stages of disclosure |
| 8168 | Identify who is responsible for the disclosure and who should be present when it is made |
| 8169 | Recognize the role of expressions of regret and when an apology should be considered in post-analysis disclosure |
| 8170 | Explain the important role of documentation of unexpected outcomes, adverse events & disclosure discussions |
| 8171 | Describe the requirement for ongoing follow-up as needed to achieve satisfactory resolution following an adverse event |
| 8172 | Recognize the need for a just culture of safety in supporting disclosure and reporting |
| 8173 | Recognize the legal implications arising from disclosure |
| |